ConductScience.org, home

Paper39665231

Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.

Padalino G and 5 others. Microbiologyopen, 2024. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms. Papers, record 39665231. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39665231

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Compounds Containing 2,3-Bis(phenylamino) Quinoxaline Exhibit Activity Against Methicillin-Resistant Staphylococcus aureus, Enterococcus faecalis, and Their Biofilms.
PubMed
Journal
Microbiologyopen
PubMed
Year
2024
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Relative citation ratio, by iCite
0.36, provisional
iCite
Revised in PubMed
2026-07-14
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Padalino GGildahttps://orcid.org/0000-0001-8580-1293
2Duggan KKatrina
3Mur LAJLuis A J
4Maillard JYJean-Yveshttps://orcid.org/0000-0002-8617-9288
5Brancale AAndrea
6Hoffmann KFKarl F

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
QuinoxalinesMajor topic
BiofilmsMajor topic
Enterococcus faecalisMajor topic
Microbial Sensitivity TestsMajor topic
Methicillin-Resistant Staphylococcus aureusMajor topic
Anti-Bacterial AgentsMajor topic
Humans

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
This work was supported by Aberystwyth University (Technology Transfer Grant Development Award) and the Life Sciences Wales Research Network (a Welsh Government Ser Cymru initiative).PubMed

Source PubMed

Download CSV of grants

References45

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137875605Quinoxalines against Leishmania amazonensis: SAR study, proposition of a new derivative, QSAR prediction, synthesis, and biological evaluation.Sci Rep2023https://conductscience.org/library/papers/37875605PubMed
229133557A Novel Mechanism of Inactivating Antibacterial Nitro Compounds in the Human Pathogen Staphylococcus aureus by Overexpression of a NADH-Dependent Flavin Nitroreductase.Antimicrob Agents Chemother2018https://conductscience.org/library/papers/29133557PubMed
337091673Understanding bacterial biofilms: From definition to treatment strategies.Front Cell Infect Microbiol2023https://conductscience.org/library/papers/37091673PubMed
421553472[Study of antibiotic resistance of enterococci strains received in 2009 in the National Reference Centre for Enterococci].Bacteriol Virusol Parazitol Epidemiol2010https://conductscience.org/library/papers/21553472PubMed
516621463Molecular epidemiology of urinary tract isolates of vancomycin-resistant Enterococcus faecium from North America.Int J Antimicrob Agents2006https://conductscience.org/library/papers/16621463PubMed
627080241Distinguishing between resistance, tolerance and persistence to antibiotic treatment.Nat Rev Microbiol2016https://conductscience.org/library/papers/27080241PubMed
733732632Antibiotic resistance: Global health crisis and metagenomics.Biotechnol Rep (Amst)2021https://conductscience.org/library/papers/33732632PubMed
836339560Identification and metabolomic characterization of potent anti-MRSA phloroglucinol derivatives from Dryopteris crassirhizoma Nakai (Polypodiaceae).Front Pharmacol2022https://conductscience.org/library/papers/36339560PubMed
925128670Present status of quinoxaline motifs: excellent pathfinders in therapeutic medicine.Eur J Med Chem2014https://conductscience.org/library/papers/25128670PubMed
1030245684The Role of Outer Membrane Proteins and Lipopolysaccharides for the Sensitivity of Escherichia coli to Antimicrobial Peptides.Front Microbiol2018https://conductscience.org/library/papers/30245684PubMed
1130826342Tackling antimicrobial resistance 2019-2024 - The UK's five-year national action plan.J Hosp Infect2019https://conductscience.org/library/papers/30826342PubMed
1223348993Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.Molecules2013https://conductscience.org/library/papers/23348993PubMed
1327620952Multidrug efflux pumps as main players in intrinsic and acquired resistance to antimicrobials.Drug Resist Updat2016https://conductscience.org/library/papers/27620952PubMed
1418274517Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.Nat Protoc2008https://conductscience.org/library/papers/18274517PubMed
1522173342What counters antibiotic resistance in nature?Nat Chem Biol2011https://conductscience.org/library/papers/22173342PubMed
1615655748Inducible clindamycin resistance in Staphylococci: should clinicians and microbiologists be concerned?Clin Infect Dis2005https://conductscience.org/library/papers/15655748PubMed
1734443334Quinoxaline Moiety: A Potential Scaffold against Mycobacterium tuberculosis.Molecules2021https://conductscience.org/library/papers/34443334PubMed
1824465654A quinoxaline derivative as a potent chemotherapeutic agent, alone or in combination with benznidazole, against Trypanosoma cruzi.PLoS One2014https://conductscience.org/library/papers/24465654PubMed
1937444780Antimicrobial Resistance: A Growing Serious Threat for Global Public Health.Healthcare (Basel)2023https://conductscience.org/library/papers/37444780PubMed
2035065702Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.Lancet2022https://conductscience.org/library/papers/35065702PubMed

See all 45 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
40641030Crossing Boundaries: A Review of the Diverse Functions of Heterocyclic Compounds in the Management of Cancer and Infectious Diseases.Curr Drug Targets2025https://conductscience.org/library/papers/40641030

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39665231

GET https://conductscience.org/api/papers/v1/39665231/references?page=2